Cargando…
Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction
Emerging evidence has shown that aldosterone blockers reduced the incidence of ventricular arrhythmias in patients with myocardial infarction (MI). However, the mechanism remains unknown. In this study, we investigated the mechanism by which spironolactone, a classic aldosterone blocker, regulates h...
Autores principales: | Yu, Hua-Dong, Xia, Shuang, Zha, Cheng-Qin, Deng, Song-Bai, Du, Jian-Lin, She, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461389/ https://www.ncbi.nlm.nih.gov/pubmed/26065643 http://dx.doi.org/10.1097/FJC.0000000000000227 |
Ejemplares similares
-
Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction
por: LIU, YAN, et al.
Publicado: (2014) -
Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
por: Minicucci, Marcos F., et al.
Publicado: (2013) -
Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015) -
Spironolactone Improves the All-Cause Mortality and Re-Hospitalization Rates in Acute Myocardial Infarction with Chronic Kidney Disease Patients
por: Qu, Xiang, et al.
Publicado: (2021) -
Salts of HCN‐Cyanide Aggregates: [CN(HCN)(2)](−) and [CN(HCN)(3)](−)
por: Bläsing, Kevin, et al.
Publicado: (2020)